InvestSMART

Cogstate Limited (ASX:CGS)

ALERT: Price-sensitive ASX Announcement for CGS
Current share price for CGS : $2.590 0.08 (3.19%)+
Announcement
Release
10 Dec 2025 8:51AM
Price at Release
$2.510
Full Release
download
Summary
Cogstate Limited (ASX: CGS) has announced an update to its financial guidance for the half-year ending 31 December 2025, attributing expected strong performance in sales contracts to a record level of pipeline opportunities. The company anticipates executing sales contracts worth approximately $37-$40 million, representing significant growth compared to the previous period. However, timing-related revenue deferrals are expected to temporarily impact reported revenue and profitability in 1H26. Revenue is forecasted to range between $25-$26 million, slightly below previous guidance. Cogstate remains optimistic about its medium- and long-term outlook, driven by a diverse range of contracts across various indications, including Alzheimer's disease and mood disorders. The company is investing in future growth drivers, such as expanding science resources and enhancing data engineering capabilities, although this will result in higher costs and reduced margins for 1H26. Management remains confident in Cogstate’s competitive position and growth strategy, with an expectation for improved margins and increased revenue recognition in 2H26.
Key Points
  • Cogstate updates financial guidance for 1H26, expecting strong sales contract performance.
  • Expected sales contracts of $37-$40 million, showing significant growth.
  • Revenue timing delays to impact profitability temporarily in 1H26.
  • Forecasted revenue range of $25-$26 million, slightly below previous guidance.
  • Company remains optimistic about medium- and long-term growth.
  • Investments in growth include expanding resources for psychiatry and data engineering.
  • Higher costs and reduced margins expected for 1H26.
  • Improved margins and increased revenue recognition anticipated for 2H26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.